Domů › Crohnova choroba › Texas › San Antonio
Klinické studie Crohnova choroba v San Antonio, TX
15 studií pro Crohnova choroba hledá účastníky v lokalitách v San Antonio a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Probíhá náborFáze 3
- Southern Star Research Institute ( Site 0299), San Antonio
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Probíhá náborFáze 3
- Southern Star Research Institute ( Site 5000), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Probíhá náborFáze 2
- Southern Star Research Institute /ID# 280822, San Antonio
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Probíhá náborFáze 2
- Sun Research Institute /ID# 266723, San Antonio
- Southern Star Research Institute /ID# 278124, San Antonio
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Gastroenterology Research of America, LLC, San Antonio
- Southern Star Research Institute, LLC, San Antonio
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2/3
- Southern Star Research Institute, LLC, San Antonio
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Probíhá náborFáze 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
- Southern Star Research Institute, LLC., San Antonio
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Probíhá náborFáze 3
- Southern Star Research Institute, LLC, San Antonio
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Southern Star Research Institute, LLC, San Antonio
Studie Crohnova choroba v jiných městech
- New York City, NY35 studií
- Cleveland, OH19 studií
- St. Louis, MO19 studií
- Boston, MA19 studií
- Miami, FL19 studií
- Orlando, FL17 studií
- Houston, TX17 studií
- Atlanta, GA17 studií
- Tyler, TX16 studií
- San Diego, CA15 studií
- Los Angeles, CA15 studií
- Philadelphia, PA13 studií
Další studie v San Antonio
- Nemalobuněčný plicní karcinom59 studií
- Kolorektální karcinom46 studií
- Rakovina prsu46 studií
- Metastatický karcinom44 studií
- Rakovina (všechny typy)41 studií
- Obesity40 studií
- Diabetes mellitus 2. typu37 studií
- Nadváha34 studií
- Rakovina vaječníků31 studií
- Rakovina slinivky břišní31 studií
- Rakovina prostaty28 studií
- Rakovina endometria27 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.